The Department of Health and Social Care has issued a strong caution to individuals born in specific years. This alert coincides with the government’s launch of a new initiative to educate young people about the risks associated with drugs such as ketamine, counterfeit medications, and tainted THC vapes.
Individuals falling within the birth years of 2001 to 2009 are being alerted about the potential consequences of consuming ketamine, synthetic opioids, or deliberately adulterated THC vapes as part of the fresh anti-drug campaign launched on October 16. The campaign primarily targets this age group.
Moreover, the campaign focuses on social media users due to a concerning uptick in drug-related harm among young individuals. Since 2015, there has been an eightfold increase in the number of individuals seeking treatment for ketamine abuse.
With a £310 million investment in drug treatment services, the campaign aligns with the government’s Plan for Change initiative, aiming to enhance community safety by mitigating serious harm from emerging drug threats.
Health Minister Ashley Dalton emphasized the significant effects of drug misuse, highlighting the risks associated with ketamine that can lead to bladder deterioration and fatal outcomes. The campaign aims to equip young people with essential information to make well-informed choices regarding their health and safety.
Educational resources will be provided to educational institutions, local health departments, and online platforms like FRANK for dissemination. Expert insights will shed light on specific risks associated with drug misuse, including the severe bladder damage caused by ketamine misuse.
Ketamine, classified as a Class B drug in the UK, carries legal repercussions for possession, distribution, or sale. The campaign also addresses concerns regarding novel synthetic opioids like nitazenes found in counterfeit medications sold online, as well as the rising harms linked to THC vapes containing synthetic cannabinoids like ‘spice.’
The campaign’s emphasis on harm reduction and access to support is crucial in light of the record-high drug poisoning deaths in England and Wales in 2023. It stresses the need for informed decision-making and awareness of available resources for those affected by drug-related issues.
The campaign underscores that despite ketamine’s medical applications, its recreational use poses significant health risks, particularly bladder-related complications. Resources will be disseminated to various sectors to provide support and information for individuals facing drug-related challenges or mental health issues.
Additionally, the Department of Health and Social Care is allocating £310 million for targeted grants to enhance drug and alcohol treatment services in England, with a focus on specialized services for young individuals. For assistance with drug-related concerns, individuals can visit www.talktofrank.com or contact the FRANK helpline at 0300 123 6600.